ࡱ> z|y)` R8bjbjl{{1%  8L64 Lvv"cKeKeKeKeKeKeK$OhR>K9 " K eKL#L#L#  @ cKL# cKL#L#E0 Ij qb!F$'J<K0LFZSl"ZSHIZS I"AL#YmKK"^L $    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limited(a joint stock company established in the People s Republic of China with limited liability)(Stock Code: 0719)APPOINTMENT OF DIRECTORsThe Board announces that with effect from 20 March 2015, Mr. Du Guanhua and Mr. Li Wenming have been appointed as the independent non-executive directors of the Company.The board of directors (the Board) of Shandong Xinhua Pharmaceutical Company Limited (the Company, together with its subsidiaries, the Group) announces that with effect from 20 March 2015, Mr. Du Guanhua (Mr. Du) and Mr. Li Wenming (Mr. Li) have been appointed as the independent non-executive directors of the Company.Mr. Du Guanhua, aged 58, is a doctor, pharmacology researcher (professor) and tutor to PhD candidates. Mr. Du obtained a Bachelor of Pharmacy from Shandong University, a Master of Medicine from Tongji Medical College and a PhD in Pharmacology from Peking Union Medical College. Mr. Du has been the head of National Center for Pharmaceutical Screening since July 1999, the chairman of Chinese Pharmacological Society since November 2007 and the deputy director of Institute of Materia Medica of Chinese Academy of Medical Sciences since September 2011. Mr. Du is currently an independent non-executive director of Shandong Luoxin Pharmacy Stock Co., Ltd and an independent director of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Save as disclosed above, Mr. Du did not hold any other directorship in any listed companies in the past three years or any other positions in the Company or other members of the Group. Mr. Du has no relationship with any other directors, senior management or substantial or controlling shareholders of the Company.As at the date hereof, Mr. Du does not have any interest in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong). Mr. Du has not entered into any service contract with the Company. His emoluments will be determined by reference to his experience and the emoluments of other independent nonexecutive directors of the Company. The term of office of Mr. Du will commence from 20 March 2015 and will end on the expiry of the term of the eighth session of the Board of the Company.Save as disclosed herein, there is nothing in respect of Mr. Du which needs to be disclosed pursuant to Rules 13.51(2)(h) to (v) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the Listing Rules) nor is there anything that needs to be brought to the attention of the shareholders of the Company.Mr. Li Wenming, aged 41, graduated from Faculty of Management of the Dalian University of Technology and obtained a Master of Business Administration. Mr. Li previously held the positions of officer of Henan Pingdingshan Zhanhe Health Bureau, market researcher of Beijing CHNMED Consulting Co., Ltd., manager of the pharmaceutical department of Beijing Peking University Founder Group and a partner of the pharmaceutical department of Beijing Hejun Consulting Co., Ltd. Mr. Li is currently a partner of Hejun Group Co., Ltd, a deputy secretary general of China Association of Pharmaceutical Commerce, an independent director of Beijing AKEC Medical Co., Ltd., a director of Beijing Tianheng Hospital Management Co., Ltd. and a director of Diacha Diagnostics Technology (Suzhou) Co., Ltd. Save as disclosed above, Mr. Li did not hold any other directorship in any listed companies in the past three years or any other positions in the Company or other members of the Group. Mr. Li has no relationship with any other directors, senior management or substantial or controlling shareholders of the Company.As at the date hereof, Mr. Li does not have any interest in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong). Mr. Li has not entered into any service contract with the Company. His emoluments will be determined by reference to his experience and the emoluments of other independent non-executive directors of the Company. The term of office of Mr. Li will commence from 20 March 2015 and will end on the expiry of the term of the eighth session of the Board of the Company.Save as disclosed herein, there is nothing in respect of Mr. Li which needs to be disclosed pursuant to Rules 13.51(2)(h) to (v) of the Listing Rules nor is there anything that needs to be brought to the attention of the shareholders of the Company.The Board takes this opportunity to welcome Mr. Du and Mr. Li to join the Board. By Order of the Board Shandong Xinhua Pharmaceutical Company Limited Zhang Daiming Chairman20 March 2015, Zibo, PRCAs at the date of this announcement, the Board comprises: Executive Directors:Mr. Zhang Daimingp q r  x 2 V X Z l νpW>92(h^h;o( h;o( ho(1hg&1hB*CJKHOJQJaJmH phsH 1hg&1hB*CJKHOJQJaJmH ph# sH Fhg&1h6B*CJKHOJPJQJ]aJmH nHo(ph# sH tH7hg&1h6B*CJKHOJQJ]aJmH ph# sH hg&1hCJKHaJ!hg&1h5CJPJ\aJo(#h5PJ\mH nHo(sH tH+jh5PJU\mHnHo(tHu haJhq s t u  x 2 X Z r s $7$8$H$Ifgdz$$7$8$G$H$Ifa$ $7$8$H$a$ $3$a$ $7$8$H$a$N ؝1$3$N ؝1$3$G$888   " # % ' : = > iUA'h^hs+mKHPJmH nHo(sH tH'h^h=kJKHPJmH nHo(sH tH7h^hzCJKHOJPJ^JaJmH nHo(sH tH'h^hKHPJmH nHo(sH tH'h^hzKHPJmH nHo(sH tH'h^haDKHPJmH nHo(sH tHh^hKHmH o(sH  h^hKHOJQJmH sH h^h;PJnHo(tHh^h>;PJnHo(tH> I N ` a q r s u )+,146˷˛ˎmm]I;I;Ih^h>KHmH o(sH 'h^h>KHPJmH nHo(sH tHh^h>5KHaJmH sH "h^h>5KH\aJmH sH h^h>KHaJmH sH h^hKHmH sH 7h^hCJKHOJPJ^JaJmH nHo(sH tH'h^haDKHPJmH nHo(sH tHh^hKHmH o(sH 'h^hs+mKHPJmH nHo(sH tH$h^hs+mKHPJmH nHsH tHs t u [\tttfX$7$8$G$H$a$gdyG$7$8$G$H$a$gdhL$7$8$G$H$a$gdaD $7$8$H$a$$7$8$G$H$a$gd> $7$8$G$H$a$[kd$$If5$$064 a 678<HIOPQRfgmnortpq˷˷˷ˁrcMcMcM+h^h42KHPJaJmH nHo(sH tHh^haDKHaJmH sH h^hKHaJmH sH h^h>KHmH sH *h^h>5KHPJmH nHo(sH tH$h^h>KHPJmH nHsH tH'h^h>KHPJmH nHo(sH tHh^h>KHmH o(sH +h^h>KHPJaJmH nHo(sH tHh^h>KHaJmH o(sH wx-.CD9:PQAC_`ŊŊv'h^h>KHPJmH nHo(sH tHh^h>KHaJmH sH +h^h1UKHPJaJmH nHo(sH tH+h^haDKHPJaJmH nHo(sH tH+h^h>KHPJaJmH nHo(sH tH+h^h42KHPJaJmH nHo(sH tHh^haDKHaJmH sH )Z[\kl{|23LM _` !ky/0ʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴʴh^hKHaJmH sH +h^htKHPJaJmH nHo(sH tH+h^h>KHPJaJmH nHo(sH tHh^h>KHaJmH sH 'h^h>5KHPJmH nHsH tH$h^h>KHPJmH nHsH tH6\ !8hw 8 $G$Ifgd?$a$$3$G$a$$3$G$a$gd{H1 $3$G$a$ $7$8$G$H$a$ $7$8$H$a$$7$8$G$H$a$gd>  !89hivwxķxhXJB?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCB 6^88s \ 8888 8  '!!l,b$l?xK-}*:B@(  N  S AB S  ?qm,tt:f\;fnn9*urn:schemas-microsoft-com:office:smarttagsplaceB*urn:schemas-microsoft-com:office:smarttagscountry-region 0u}<C {ls 113344679:<=EHRUVknu+113344679:<=EHRUVkn3"=113344679:<=UVn113344679:<=UVnQ*.7/S dWe$(jD^ߎB\* Gp^$4ZbF-RҨLHN S %Z^oRa6bJE dŚ utXhh^h`o(.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH. @^`@o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .u?u^u`?o(.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.?^`?o(?^`?o(.0^`0o(..0^`0o(... 88^8`o( .... 88^8`o( ..... `^``o(...... `^``o(....... ^`o(........ ?^`?B*o(ph.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.  ^` o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` . ^` o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .0^`0o(() ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` . @^`@5o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .  ^` o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .0^`0PJo(() H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.  ^` o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .  ^` o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` . ^`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .WQ^\*  utE dBRa7/S LH Sp^$F-%Z^        v>T[                ڤO        p@B        2ZJ        B:T                Fg3         8        Vj        @         Z)        `        @?Q2lM?>+b!+8'_+,0g&1{H1y142 A9BSCD0ZFtH=kJ1U>YZN`D:eA"gs+m-wqtvt.v}t^* `HhLpe8lvvE1aD^5z}`z}-nyGxt B3#,,xNO"<45 CM./0VWXYZ[\]^_`abcdefghijniM99S+0S+0S+0S+0S+0S+0S+0S+0S+0S+0@  4uusmP@P P@Pp@UnknownGz Times New Roman5Symbol3& z Arial;[SOSimSunC .PMingLiUe0}fԚaTimes-ItalicTimes New Roman_ Times-RomanTimes New RomanMTimesLTStd-Bold[SOKE  DFKai-SBPMingLiU?5 .MingLiU0}fԚU Arial Unicode MSArialKPMCHM I+ Times[SO7&  Verdana 1hsF!3 sF+3) &) &!?!),.:;?]}    " % & ' 2 t%00 0 000000013468:<>@BDOPQRTUVWZ\^ \]d([{  5 0 0 00000579;=?ACY[][d''2qHX?>Y2~The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation CharltonshggSfH          Oh+'0(4HT`p    The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation CharltonsNormal43Microsoft Office Word@@`S@6]%S@Nb)՜.+,0 X`t|  Charltons& ''   !"#$%&'()*+,-./012345689:;<=>@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghjklmnoprstuvwx{Root Entry F$rb}Data 71Table?SWordDocumentlSummaryInformation(iDocumentSummaryInformation8qCompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q